Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Bunkyo, TokyoFounded 200774 employeesWebsite
Japan's leading drugstore group formed by the merger of Matsumotokiyoshi and Cocokara Fine. It excels in urban store development and private brand product strategies.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Matsumotokiyoshi Drugstore Group Business | 64% | ¥711.4B | ¥60.8B | 8.5% |
| Cocokara Fine Group Business | 35% | ¥390.0B | ¥23.5B | 6.0% |
| And Company Business | 1% | ¥12.9B | ¥200M | 1.5% |
Close (Oct 30, 2026)
¥2,604-5.7% (1Y)
MatsukiyoCocokara -5.7% over 1Y, 10.5pt below the industry average (55 companies, +4.9%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥1.1T | ¥84.9B | ¥55.8B | ¥755.8B | +5.3% |
| 2025FY | ¥1.1T | ¥82.1B | ¥54.7B | ¥712.8B | +3.8% |
| 2024FY | ¥1.0T | ¥75.7B | ¥52.3B | ¥724.7B | +7.5% |
| 2023FY | ¥951.2B | ¥62.3B | ¥40.5B | ¥688.1B | +30.3% |
| 2022FY | ¥730.0B | ¥41.1B | ¥34.4B | ¥652.5B | +34.0% |
| 2021FY | ¥544.7B | ¥31.6B | ¥21.6B | ¥368.9B | — |
Sources: annual securities reports, earnings releases and other public disclosures (May 2025)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
